Statement Of Cash Flows [Abstract]

Generix Group S.A. - Filing #873306

Concept 2021-04-01 to
2022-03-31
As at
2022-03-31
As at
2021-03-31
2020-04-01 to
2021-03-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Cash flows from (used in) operating activities
12 456 EUR
11 529 EUR
Cash flows from (used in) investing activities [abstract]
Cash flows used in obtaining control of subsidiaries or other businesses, classified as investing activities
2 000 EUR
3 400 EUR
Purchase of property, plant and equipment, classified as investing activities
1 069 EUR
1 424 EUR
Purchase of intangible assets, classified as investing activities
304,000 EUR
551,000 EUR
Proceeds from sales of other long-term assets, classified as investing activities
20,000 EUR
11,000 EUR
Purchase of other long-term assets, classified as investing activities
7,000 EUR
51,000 EUR
Cash flows from (used in) investing activities
6 744 EUR
7 129 EUR
Cash flows from (used in) financing activities [abstract]
Proceeds from borrowings, classified as financing activities
2 138 EUR
3 289 EUR
Repayments of borrowings, classified as financing activities
6 552 EUR
4 833 EUR
Dividends paid, classified as financing activities
1 271 EUR
873,000 EUR
Cash flows from (used in) financing activities
5 773 EUR
2 382 EUR
Effect of exchange rate changes on cash and cash equivalents [abstract]
Effect of exchange rate changes on cash and cash equivalents
56,000 EUR
24,000 EUR
Increase (decrease) in cash and cash equivalents after effect of exchange rate changes
116,000 EUR
1 994 EUR
Cash and cash equivalents
15 515 EUR
14 511 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.